IT7941669A0 - N-(fenossialchile)immidazoli, relative composizioni farmaceutiche e procedimento per la loro fabbricazione. - Google Patents

N-(fenossialchile)immidazoli, relative composizioni farmaceutiche e procedimento per la loro fabbricazione.

Info

Publication number
IT7941669A0
IT7941669A0 IT7941669A IT4166979A IT7941669A0 IT 7941669 A0 IT7941669 A0 IT 7941669A0 IT 7941669 A IT7941669 A IT 7941669A IT 4166979 A IT4166979 A IT 4166979A IT 7941669 A0 IT7941669 A0 IT 7941669A0
Authority
IT
Italy
Prior art keywords
phenoxyalkyl
imidazoles
procedure
manufacturing
pharmaceutical compositions
Prior art date
Application number
IT7941669A
Other languages
English (en)
Other versions
IT1194900B (it
Inventor
Cross Peter Edward
Dickinson Roger Peter
Original Assignee
Colon Panama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT7941669(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colon Panama filed Critical Colon Panama
Publication of IT7941669A0 publication Critical patent/IT7941669A0/it
Application granted granted Critical
Publication of IT1194900B publication Critical patent/IT1194900B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT41669/79A 1978-12-13 1979-12-11 N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione IT1194900B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (2)

Publication Number Publication Date
IT7941669A0 true IT7941669A0 (it) 1979-12-11
IT1194900B IT1194900B (it) 1988-09-28

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
IT41669/79A IT1194900B (it) 1978-12-13 1979-12-11 N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione

Country Status (34)

Country Link
US (2) US4602016A (it)
JP (1) JPS585197B2 (it)
KR (1) KR830001243B1 (it)
AR (1) AR227637A1 (it)
AT (1) AT373879B (it)
AU (1) AU517892B2 (it)
BE (1) BE880584A (it)
CA (1) CA1108137A (it)
CH (1) CH644597A5 (it)
CS (1) CS216517B2 (it)
DD (1) DD147943A5 (it)
DE (1) DE2950019A1 (it)
DK (1) DK471479A (it)
EG (1) EG14227A (it)
ES (1) ES486782A0 (it)
FI (1) FI70888C (it)
FR (1) FR2444031A1 (it)
GB (1) GB2038821B (it)
GR (1) GR73003B (it)
HU (1) HU183016B (it)
IE (1) IE49318B1 (it)
IL (1) IL58917A (it)
IT (1) IT1194900B (it)
LU (1) LU81985A1 (it)
NL (1) NL177749C (it)
NO (1) NO153135C (it)
NZ (1) NZ192360A (it)
PH (1) PH15056A (it)
PL (1) PL134005B1 (it)
PT (1) PT70571A (it)
SE (1) SE444937B (it)
SU (1) SU878195A3 (it)
YU (1) YU301879A (it)
ZA (1) ZA796708B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES8601148A1 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
SU1739848A3 (ru) 1986-01-28 1992-06-07 Санкио Компани Лимитед (Фирма) Способ получени производных тианафтена или их фармацевтически приемлемых солей
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
ATE57925T1 (de) * 1987-04-03 1990-11-15 Cl Pharma Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
ES2201104T3 (es) * 1994-04-26 2004-03-16 Roche Palo Alto Llc Derivados de benzociclohexilimidazoltiona.
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
CA2491848A1 (en) * 2002-07-09 2004-01-15 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor
AU2004264722A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
BR112014029161A2 (pt) * 2012-05-22 2017-06-27 Genentech Inc benzamidas n-substituídas e seu uso no tratamento de dor
US9388179B2 (en) 2012-10-26 2016-07-12 Merck Sharp & Dohme Corp. N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
JP2025518969A (ja) * 2022-06-13 2025-06-19 合肥医工医薬股▲フン▼有限公司 イミダゾリジニルバニリン酸エーテル誘導体およびその使

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
NZ192360A (en) 1982-02-23
SE7910204L (sv) 1980-06-14
DE2950019A1 (de) 1980-07-10
ES8101556A1 (es) 1980-12-16
ZA796708B (en) 1981-08-26
ES486782A0 (es) 1980-12-16
NO153135C (no) 1986-01-22
FI793868A7 (fi) 1980-06-14
FI70888B (fi) 1986-07-18
AR227637A1 (es) 1982-11-30
FR2444031A1 (fr) 1980-07-11
BE880584A (fr) 1980-06-12
PH15056A (en) 1982-06-03
IL58917A0 (en) 1980-03-31
PL134005B1 (en) 1985-07-31
SE444937B (sv) 1986-05-20
DK471479A (da) 1980-06-14
CH644597A5 (de) 1984-08-15
JPS5585572A (en) 1980-06-27
AU5372579A (en) 1980-06-19
IL58917A (en) 1984-03-30
JPS585197B2 (ja) 1983-01-29
US4602016A (en) 1986-07-22
NL7908899A (nl) 1980-06-17
AT373879B (de) 1984-02-27
LU81985A1 (fr) 1980-04-22
KR830001243B1 (ko) 1983-06-27
FR2444031B1 (it) 1983-06-10
GB2038821B (en) 1982-12-08
IT1194900B (it) 1988-09-28
PT70571A (en) 1980-01-01
NL177749B (nl) 1985-06-17
CA1108137A (en) 1981-09-01
GB2038821A (en) 1980-07-30
DD147943A5 (de) 1981-04-29
EG14227A (en) 1983-12-31
CS216517B2 (en) 1982-11-26
NO153135B (no) 1985-10-14
AU517892B2 (en) 1981-09-03
SU878195A3 (ru) 1981-10-30
PL220351A1 (it) 1980-12-01
YU301879A (en) 1983-01-21
ATA783379A (de) 1983-07-15
KR830001242A (ko) 1983-04-29
NO794069L (no) 1980-06-16
US4636500A (en) 1987-01-13
FI70888C (fi) 1986-10-27
GR73003B (it) 1984-01-24
HU183016B (en) 1984-04-28
IE792403L (en) 1980-06-13
NL177749C (nl) 1985-11-18
IE49318B1 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
IT1194900B (it) N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
IT7821444A0 (it) 1, 3, 4,-tiadiazol-2-il-uree, procedimento per la loro preparazione e loro impiego come fungicidi.
IT7922036A0 (it) 1,3-diaril-2-imino-imidazolidine e 2-imino-esaidro-pirimidine sostituite e procedimento per la loro preparazione.
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
IT8023315A0 (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione.
IT7921898A0 (it) Composti erbicidi e procedimento per la loro preparazione.
IT7927243A0 (it) Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
IT8023208A0 (it) Eteri ossimici, loro preparazione e composizioni farmaceutiche che licontengono.
IT7925387A0 (it) 2-amminoetil-1-fenil-indoline, loro preparazione e loro applicazione come medicamenti.
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT7922035A0 (it) Alcossialchilidenidrazinopiridazine e procedimento per la loro preparazione.
IT1164677B (it) Derivati di 1,3 benzodiossina procedimento per la loro produzione e composizioni farmaceutiche che li contengono come incredienti attivi
IT7829164A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT8019098A0 (it) 3, 4-epossipirrolidine 1-sostituite e procedimento per la loro preparazione.
IT8024812A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT7926014A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT7828232A0 (it) Peptidi, procedimento per la loro preparazione, e composizioni farmaceutiche comprendenti tali peptidi.
IT8019782A0 (it) Composti farmaceuticamente attivi e procedimento per la loro produzione.
IT7823093A0 (it) Benzil-pirimidine e procedimento per la loro preparazione.
IT8024193A0 (it) Composizioni dermatologiche eprocedimento per la loro preparazione.
IT8124004A0 (it) Farmaceuticamente attive, aril-alchil-piperazine procedimenti per la loro preparazione e composizioni relative.
IT1100690B (it) 1-(3-metil-5-isotiazo.il)-3-alcossi-3-metiluree,particolarmente utilizzati come erbicidi,e procedimento per la loro preparazione